GB201518171D0 - Colloidal particles for topical administration with therapeutic agent - Google Patents

Colloidal particles for topical administration with therapeutic agent

Info

Publication number
GB201518171D0
GB201518171D0 GBGB1518171.2A GB201518171A GB201518171D0 GB 201518171 D0 GB201518171 D0 GB 201518171D0 GB 201518171 A GB201518171 A GB 201518171A GB 201518171 D0 GB201518171 D0 GB 201518171D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agent
topical administration
colloidal particles
colloidal
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1518171.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cantab Biopharmaceuticals Patents Ltd
Original Assignee
Cantab Biopharmaceuticals Patents Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cantab Biopharmaceuticals Patents Ltd filed Critical Cantab Biopharmaceuticals Patents Ltd
Priority to GBGB1518171.2A priority Critical patent/GB201518171D0/en
Publication of GB201518171D0 publication Critical patent/GB201518171D0/en
Priority to PCT/EP2016/074783 priority patent/WO2017064289A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1518171.2A 2015-10-14 2015-10-14 Colloidal particles for topical administration with therapeutic agent Ceased GB201518171D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1518171.2A GB201518171D0 (en) 2015-10-14 2015-10-14 Colloidal particles for topical administration with therapeutic agent
PCT/EP2016/074783 WO2017064289A1 (en) 2015-10-14 2016-10-14 Colloidal particles for topical administration with therapeutic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1518171.2A GB201518171D0 (en) 2015-10-14 2015-10-14 Colloidal particles for topical administration with therapeutic agent

Publications (1)

Publication Number Publication Date
GB201518171D0 true GB201518171D0 (en) 2015-11-25

Family

ID=55131024

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1518171.2A Ceased GB201518171D0 (en) 2015-10-14 2015-10-14 Colloidal particles for topical administration with therapeutic agent

Country Status (2)

Country Link
GB (1) GB201518171D0 (en)
WO (1) WO2017064289A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202111757D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles for use in the treatment of haemophilia A
GB202111759D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles
GB202111758D0 (en) * 2021-08-17 2021-09-29 Cantab Biopharmaceuticals Patents Ltd Modified colloidal particles for use in the treatment of haemophilia A

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
AU7384994A (en) 1993-08-06 1995-02-28 Opperbas Holding B.V. A method for high loading of vesicles with biopolymeric substances
EP1079805B1 (en) 1998-04-27 2004-11-24 Opperbas Holding B.V. Pharmaceutical composition comprising factor viii and neutral liposomes
ATE317869T1 (en) 1999-07-14 2006-03-15 Alza Corp NEUTRAL LIPOPOLYMER AND LIPOSOMAL COMPOSITIONS THEREOF
US20030232075A1 (en) * 2002-05-06 2003-12-18 University Of Minnesota, A Minnesota Corporation Compositions for producing factor Xa
MXPA05010926A (en) 2003-04-15 2005-11-25 Opperbas Holding Bv Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles.
EP1898939A2 (en) * 2005-06-29 2008-03-19 The Research Foundation of State of University Of New York at Buffalo Compositions and methods for less immunogenic pr0tein-lip1d complexes
EP2437726B1 (en) 2009-06-03 2018-05-16 Sequessome Technology Holdings Limited Formulations for the treatment of deep tissue pain
NZ598906A (en) 2009-08-21 2014-08-29 Targeted Delivery Technologies Ltd Vesicular formulations
GB201007357D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIII
GB201007356D0 (en) 2010-04-30 2010-06-16 Leverton Licence Holdings Ltd Conjugated factor VIIa
PE20150226A1 (en) 2012-04-16 2015-02-14 Cantab Biopharmaceuticals Patent Ltd OPTIMIZED THERAPEUTIC AGENTS FOR SUBCUTANEOUS ADMINISTRATION

Also Published As

Publication number Publication date
WO2017064289A1 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
HK1221672A1 (en) Nasal administration
PT3442480T (en) Topical administration method
EP2968739A4 (en) Infusion systems for the controlled delivery of therapeutic agents
HK1245680A1 (en) Therapeutic agent for meibomian dysfunction
HK1231390A1 (en) Pharmaceutical composition for topical administration
HK1208378A1 (en) Pharmaceutical composition for the treatment of fungal infections
HK1222548A1 (en) Pharmaceutical combinations for the treatment of cancer
EP3177304A4 (en) Therapeutic nanoparticles for accumulation in the brain
GB201502845D0 (en) Topical pharmaceutical formulation
HK1256814A1 (en) Colloidal particles for use in medicine
EP2987531A4 (en) Particle therapy system
GB201518171D0 (en) Colloidal particles for topical administration with therapeutic agent
EP3046556A4 (en) Combination drug therapy
EP3150211A4 (en) Therapeutic agent for keratoconjunctive disorder
EP3095453A4 (en) Topical agent for transdermal administration
EP3040071A4 (en) Therapeutic agent for dyslipidemia
EP2958570A4 (en) Therapeutic composition for the treatment perianal disorders
EP2979695A4 (en) Therapeutic agent for eye disorder
EP3338779A4 (en) Tumor therapeutic agent
GB201911521D0 (en) Therapeutic agent
GB201516109D0 (en) Therapeutic agent
EP2990043A4 (en) Therapeutic agent for neurological disorder
GB201301385D0 (en) Particle structures for drug delivery
HUE050066T2 (en) Therapeutic agent for meibomian dysfunction

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)
S30Z Assignments for licence or security reasons

Free format text: APPLICANT. CANTAB BIOPHARMACEUTICALS PATENTS LIMITED SECURITY INTEREST. FONDS RUSNANO CAPITAL S.A.